(Q40820613)

24 September 2017

title

Inhibition of tumor metastasis by adoptive transfer of IL-12-activated Valpha14 NKT cells (English)

1 reference

24 September 2017

1 reference

T Shin

1

1 reference

24 September 2017

T Nakayama

2

1 reference

24 September 2017

Y Akutsu

3

1 reference

24 September 2017

S Motohashi

4

1 reference

24 September 2017

Y Shibata

5

1 reference

24 September 2017

M Harada

6

1 reference

24 September 2017

N Kamada

7

1 reference

24 September 2017

C Shimizu

8

1 reference

24 September 2017

E Shimizu

9

1 reference

24 September 2017

T Saito

10

1 reference

24 September 2017

T Ochiai

11

1 reference

24 September 2017

M Taniguchi

12

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

International Journal of Cancer

24 September 2017

published in

1 reference

24 September 2017

volume

91

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

523-528

1 reference

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

The cell envelope structure of the lipopolysaccharide-lacking gram-negative bacterium Sphingomonas paucimobilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Differential tumor surveillance by natural killer (NK) and NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

V alpha 14+ NK T cells: a novel lymphoid cell lineage with regulatory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

Interleukin-12: a cytokine at the interface of inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%2820010215%2991%3A4%3C523%3A%3AAID-IJC1087%3E3.0.CO%3B2-L

10.1002/1097-0215(20010215)91:4<523::AID-IJC1087>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference